Viatar CTC Solutions to Present at 8th Annual LD Micro Main Event Conference

Nov. 30, 2015 8:01 am

LOWELL, MA--(Marketwired - Nov 30, 2015) - Viatar CTC Solutions, Inc. (OTCQB: VRTT), a medical technology company focused on the treatment of patients with metastatic cancer, today announced that Ilan Reich, Chairman and Chief Executive Officer, will present a corporate overview at the 8th Annual LD Micro Main Event being held on December 1-3, 2015 at the Luxe Sunset Hotel, Los Angeles, CA.

Mr. Reich will present on Thursday December 3, 2015 at 1:00 pm PT and will be available for one-on-one meetings on December 2-3, 2015.

About Viatar CTC Solutions

Viatar CTC Solutions Inc. is a medical technology company focused on the treatment of patients with metastatic cancer. The company's lead product, the Viatar™ Therapeutic Oncopheresis System, removes circulating tumor cells from whole blood using label-free cross-flow filtration. Pending regulatory approval targeted for 2016, it will be used as a periodic therapy to improve overall survival for a wide range of solid tumor types such as lung, breast, colon, prostate and gastric cancers. This proprietary technology also powers the company's liquid biopsy products, which are collection systems for use by genetic testing companies, researchers and medical oncologists that provide a greater quantity and purity of circulating tumor cells for their molecular analysis and personalized medicine objectives.

For More Information:

For Viatar CTC Solutions:
Ilan Reich
Chairman& CEO

Investor Contacts:
Stephanie Prince
PCG Advisory Group

Dave Gentry
RedChip Companies
407-644-4256, ext. 104

Media Contact:
Sean Leous
PCG Advisory Group

Marketwired (Canada)
November 30, 2015 - 8:01 AM EST

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market